Skip to main content
Top

International Journal of Clinical Oncology

Issue 4/2006

Content (14 Articles)

INTRODUCTION TO REVIEW ARTICLES

Oncology imaging: current status and new approaches

Hisao Ito

REVIEW ARTICLE

Trends in oncological CT imaging: clinical application of multidetector-row CT and 3D-CT imaging

Takuya Ueda, Kensaku Mori, Manabu Minami, Ken Motoori, Hisao Ito

REVIEW ARTICLE

Current status of body MR imaging: fast MR imaging and diffusion-weighted imaging

Takashi Koyama, Ken Tamai, Kaori Togashi

REVIEW ARTICLE

PET and PET/CT using 18F-FDG in the diagnosis and management of cancer patients

Keigo Endo, Noboru Oriuchi, Tetsuya Higuchi, Yasuhiko Iida, Hirofumi Hanaoka, Mitsuyuki Miyakubo, Tomohiro Ishikita, Keiko Koyama

ORIGINAL ARTICLE

The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer

Norio Nonomura, Yasutomo Nakai, Masashi Nakayama, Hitoshi Inoue, Kazuo Nishimura, Eijirou Hatanaka, Ryouichi Arima, Tomomi Kishimoto, Tsuneharu Miki, Hideya Kuroda, Akihiko Okuyama

ORIGINAL ARTICLE

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

Senji Hoshi, Osamu Yamaguchi, Tomoaki Fujioka, Yoichi Arai, Yoshihiko Tomita, Tomonori Habuchi, Chikara Ohyama, Tadashi Suzuki, Seiichi Orikasa

ORIGINAL ARTICLE

Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: a phase I study in Japanese patients with cancer of the uterine cervix

Yoh Watanabe, Hidekatsu Nakai, Masao Shimaoka, Takako Tobiume, Isao Tsuji, Hiroshi Hoshiai

ORIGINAL ARTICLE

Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer

Masashi Kobayashi, Kaoru Matsui, Tomonori Hirashima, Takashi Nitta, Shinji Sasada, Takuhito Tada, Kazuo Minakuchi, Mitsugi Furukawa, Yoshitaka Ogata, Ichiro Kawase

ORIGINAL ARTICLE

Serial changes of international prostate symptom score following I-125 prostate brachytherapy

Toshio Ohashi, Atsunori Yorozu, Kazuhito Toya, Shiro Saito, Tetsuo Momma

CASE REPORT

Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer

Shinya Yamamoto, Jyunji Yonese, Satoru Kawakami, Tetsuro Tsukamoto, Yuhei Ohkubo, Manabu Tatokoro, Iwao Fukui

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine